TY  - JOUR
AU  - Tomczak, Aurelie
AU  - Springfeld, Christoph
AU  - Dill, Michael T
AU  - Chang, De-Hua
AU  - Kazdal, Daniel
AU  - Wagner, Ursula
AU  - Mehrabi, Arianeb
AU  - Brockschmidt, Antje
AU  - Luedde, Tom
AU  - Naumann, Patrick
AU  - Stenzinger, Albrecht
AU  - Schirmacher, Peter
AU  - Longerich, Thomas
TI  - Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
JO  - British journal of cancer
VL  - 127
IS  - 9
SN  - 0007-0920
CY  - Edinburgh
PB  - Nature Publ. Group
M1  - DKFZ-2022-01927
SP  - 1701-1708
PY  - 2022
N1  - 2022 Nov;127(9):1701-1708
AB  - Advanced cholangiocarcinoma has a poor prognosis. Molecular targeted approaches have been proposed for patients after progression under first-line chemotherapy treatment. Here, molecular profiling of intrahepatic cholangiocarcinoma in combination with a comprehensive umbrella concept was applied in a real-world setting.In total, 101 patients received molecular profiling and matched treatment based on interdisciplinary tumour board decisions in a tertiary care setting. Parallel DNA and RNA sequencing of formalin-fixed paraffin-embedded tumour tissue was performed using large panels.Genetic alterations were detected in 77
LB  - PUB:(DE-HGF)16
C6  - pmid:35986087
DO  - DOI:10.1038/s41416-022-01932-1
UR  - https://inrepo02.dkfz.de/record/181300
ER  -